XHKG
1338
Market cap12mUSD
Oct 09, Last price
0.03HKD
1D
6.25%
1Q
9.68%
Jan 2017
-91.05%
IPO
-98.92%
Name
BaWang International Group Holding Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BaWang International (Group) Holding Limited, operating with its subsidiaries, specializes in the development, production, sale, and distribution of products based on traditional Chinese herbs. The company's reach extends across the People's Republic of China, Hong Kong, Thailand, and Malaysia. Its business is divided into segments focusing on Hair-Care, Skin-Care, and a broader category of Other Household and Personal Care Products. Under brand names such as Bawang, Royal Wind, Herborn, and Litao, the firm provides a diverse portfolio of goods including various shampoos, hair treatments, skincare essentials, household cleaners, shower gels, laundry detergents, and anti-bacterial hand sanitizers. These items are made available to consumers through a network of distributors, traditional retail outlets, and its online sales channels. Beyond its herbal specialties, BaWang is also involved in the manufacturing, promotion, and trading of a general range of household and personal grooming products. Established in 2007, the company maintains its primary offices in Guangzhou, People's Republic of China, and functions as a subsidiary of Fortune Station Limited.
Key people
Qiyuan Chen
Executive Chairman of the Board · since 2007
Zheng He Chen
Chief Executive Officer, Executive Director · since 2015
Sin Yung Wong
Chief Financial Officer, Company Secretary, Executive Director · since 2008
Xingzhi Lu
Company Secretary · since 2025
Independent Non-Executive Director · since 2014
Tat Hoi Chu
Independent Non-Executive Director · since 2024
Jing Liu
Independent Non-Executive Director · since 2022
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||